Artificial forms of somatostatin, a hormone that influences the pituitary gland’s regulation of growth hormone discharge, are employed for treating acromegaly and the symptoms linked to specific hormone-releasing tumors, notably in cases of carcinoid syndrome. Octreotide stands out as a prevalent variant of somatostatin analog.